{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T16:22:58Z","timestamp":1790266978400,"version":"4.1.0"},"reference-count":80,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2000,2,1]],"date-time":"2000-02-01T00:00:00Z","timestamp":949363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2000,2]]},"DOI":"10.1006\/nbdi.1999.0273","type":"journal-article","created":{"date-parts":[[2002,9,18]],"date-time":"2002-09-18T19:46:43Z","timestamp":1032378403000},"page":"23-37","source":"Crossref","is-referenced-by-count":158,"title":["Oxidative Insults Are Associated with Apolipoprotein E Genotype in Alzheimer's Disease Brain"],"prefix":"10.1006","volume":"7","author":[{"given":"Charles","family":"Ramassamy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Averill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe","family":"Beffert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Theroux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Lussier-Cacan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey S.","family":"Cohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Christen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Schoofs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Davignon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judes","family":"Poirier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1006\/nbdi.1999.0273_RF1","first-page":"213","article-title":"Alzheimer's and Parkinson's disease. Brain levels of glutathione, glutathione disulfide and vitamine E","volume":"14","author":"Adams","year":"1991","journal-title":"Mol. Chem. Pathol"},{"key":"10.1006\/nbdi.1999.0273_RF2","first-page":"21","article-title":"Catalase in vitro","volume":"105","author":"Aebi","year":"1984","journal-title":"Methods Enzymol"},{"key":"10.1006\/nbdi.1999.0273_RF3","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/0891-5849(95)02149-3","article-title":"Glucose, glutathione and cellular response to spermine oxidation products","volume":"20","author":"Agostinelli","year":"1996","journal-title":"Free Radical Biol. Med."},{"key":"10.1006\/nbdi.1999.0273_RF4","series-title":"Handbook of Methods for Oxygen Radical Research","first-page":"317","author":"Anderson","year":"1989"},{"key":"10.1006\/nbdi.1999.0273_RF5","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0306-4522(97)00598-8","article-title":"Behavioural, physiological and morphological analysis of a line of apolipoprotein E knockout mouse","volume":"85","author":"Anderson","year":"1998","journal-title":"Neuroscience"},{"key":"10.1006\/nbdi.1999.0273_RF6","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1523\/JNEUROSCI.17-02-00516.1997","article-title":"Plastic neuronal remodeling is impaired in patients with Alzheimer's disease carrying apolipoprotein \u03f54 allele","volume":"17","author":"Arendt","year":"1997","journal-title":"J. Neurosci."},{"key":"10.1006\/nbdi.1999.0273_RF7","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0165-0173(97)00045-3","article-title":"Neurodegenerative disorders in humans: The role of glutathione in oxidative stress-mediated neuronal death","volume":"25","author":"Bains","year":"1997","journal-title":"Brain Res. Rev."},{"key":"10.1006\/nbdi.1999.0273_RF8","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1007\/BF00965146","article-title":"Evidence of antioxidative challenge in the Alzheimer's brain","volume":"19","author":"Balazs","year":"1994","journal-title":"Neurochem. Res."},{"key":"10.1006\/nbdi.1999.0273_RF9","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/0304-3940(94)11107-T","article-title":"Apolipoprotein E4 allele and disease progression in patients with late-onset Alzheimer's disease","volume":"183","author":"Basun","year":"1995","journal-title":"Neurosci. Lett."},{"key":"10.1006\/nbdi.1999.0273_RF10","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1749-6632.1996.tb34415.x","article-title":"Apolipoprotein E, plaques, tangles and cholinergic dysfunction in Alzheimer's disease","volume":"777","author":"Beffert","year":"1996","journal-title":"Ann. N. Y. Acad. Sci"},{"key":"10.1006\/nbdi.1999.0273_RF11","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0006-8993(99)01894-6","article-title":"Apolipoprotein E and \u03b2-amyloid levels in the hippocampus and frontal cortex of Alzheimer's disease subjects are disease-related and apolipoprotein E genotype dependent","volume":"843","author":"Beffert","year":"1999","journal-title":"Brain. Res."},{"key":"10.1006\/nbdi.1999.0273_RF12","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/0092-8674(94)90131-7","article-title":"Hydrogen peroxide mediates amyloid \u03b2 protein toxicity","volume":"77","author":"Behl","year":"1994","journal-title":"Cell"},{"key":"10.1006\/nbdi.1999.0273_RF13","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/0169-328X(95)00097-C","article-title":"Association of apolipoprotein E and apolipoprotein J (clusterin) in Alzheimer's disease","volume":"33","author":"Bertrand","year":"1995","journal-title":"Brain Res."},{"key":"10.1006\/nbdi.1999.0273_RF14","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/0003-2697(89)90101-2","article-title":"Protein measurement using bicinchoninic acid: Elimination of interfering substances","volume":"189","author":"Brown","year":"1989","journal-title":"Anal. Biochem."},{"key":"10.1006\/nbdi.1999.0273_RF15","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1161\/01.ATV.16.1.149","article-title":"Plasma concentration of apolipoprotein E in intermediate-sized remnant-like lipoproteins in normolipidemic and hyperlipidemic subjects","volume":"16","author":"Cohn","year":"1996","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1006\/nbdi.1999.0273_RF16","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1126\/science.8346443","article-title":"Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families","volume":"261","author":"Corder","year":"1993","journal-title":"Science"},{"key":"10.1006\/nbdi.1999.0273_RF17","doi-asserted-by":"crossref","first-page":"6240","DOI":"10.1016\/S0021-9258(18)88963-3","article-title":"Isolation, characterisation and mapping to chromosome 19 of the human APOE gene","volume":"260","author":"Das","year":"1985","journal-title":"J. Biol. Chem."},{"key":"10.1006\/nbdi.1999.0273_RF18","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0891-5849(91)90192-6","article-title":"Chemistry and biochemistry of 4-hydroxy-2-nonenal, malonaldehyde and related aldehydes","volume":"11","author":"Esterbauer","year":"1991","journal-title":"Free Radical Biol. Med."},{"key":"10.1006\/nbdi.1999.0273_RF19","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1006\/exnr.1998.6818","article-title":"Evidence for normal aging of the septo-hippocampal cholinergic system in apoE (\u2212\/\u2212) mice but impaired clearance of axonal degeneration products following injury","volume":"151","author":"Fagan","year":"1998","journal-title":"Exp. Neurol."},{"key":"10.1006\/nbdi.1999.0273_RF20","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1212\/WNL.50.3.669","article-title":"Treatment outcome of tacrine therapy depends on apolipoprotein genotype and gender of the subjects with Alzheimer's disease","volume":"50","author":"Farlow","year":"1998","journal-title":"Neurology"},{"key":"10.1006\/nbdi.1999.0273_RF21","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1002\/ana.410370509","article-title":"Gene dose of the \u03f54 allele of apolipoprotein E and disease progression in sporadic late-onset Alzheimer's disease","volume":"37","author":"Frisoni","year":"1995","journal-title":"Ann. Neurol."},{"key":"10.1006\/nbdi.1999.0273_RF22","first-page":"621","article-title":"Evidence for neuronal oxidative damage in Alzheimer's disease","volume":"140","author":"Good","year":"1996","journal-title":"Am. J. Pathol."},{"key":"10.1006\/nbdi.1999.0273_RF23","first-page":"5231","article-title":"Metabolism of 4-hydroxynonenal, a cytotoxic lipid peroxidation product, in Ehrlich mouse ascites cells at different proliferation stages","volume":"54.","author":"Grune","year":"1994","journal-title":"Cancer Res."},{"key":"10.1006\/nbdi.1999.0273_RF24","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1046\/j.1471-4159.1995.64031216.x","article-title":"Decreased catalase activity but unchanged superoxide dismutase activity in brains of patients with dementia of Alzheimer type","volume":"64","author":"Gsell","year":"1995","journal-title":"J. Neurochem."},{"key":"10.1006\/nbdi.1999.0273_RF25","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0304-3940(97)13477-2","article-title":"Levels of cerebrospinal fluid apolipoprotein E in patients with Alzheimer's disease and healthy controls","volume":"224","author":"Hahne","year":"1997","journal-title":"Neurosci. Lett."},{"key":"10.1006\/nbdi.1999.0273_RF26","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0014-4886(95)90041-1","article-title":"Direct evidence of oxidative injury produced by the Alzheimer's \u03b2-amyloid peptide (1\u201340) in cultured hippocampal neurons","volume":"131","author":"Harris","year":"1995","journal-title":"Exp. Neurol."},{"key":"10.1006\/nbdi.1999.0273_RF27","doi-asserted-by":"crossref","first-page":"3270","DOI":"10.1073\/pnas.91.8.3270","article-title":"A model for \u03b2-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: Relevance to Alzheimer disease","volume":"91","author":"Hensley","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/nbdi.1999.0273_RF28","first-page":"3986","article-title":"Genomic instability and catalase amplification induced by chronic exposure to oxidative stress","volume":"58","author":"Hunt","year":"1998","journal-title":"Cancer Res."},{"key":"10.1006\/nbdi.1999.0273_RF29","doi-asserted-by":"crossref","first-page":"3586","DOI":"10.1073\/pnas.92.8.3586","article-title":"Quantitative analysis of senile plaques in Alzheimer's disease: Observation of log-normal size distribution and molecular epidemiology of differences associated with apolipoprotein E genotype and trisomy 21","volume":"92","author":"Hyman","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/nbdi.1999.0273_RF30","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1001\/archneur.1985.04060100083029","article-title":"Diagnosis of Alzheimer's disease","volume":"42","author":"Khachaturian","year":"1985","journal-title":"Arch. Neurol."},{"key":"10.1006\/nbdi.1999.0273_RF31","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/BF00225071","article-title":"Apolipoprotein E (APOE) polymorphism and its influence on apoE concentrations in the cerebrospinal fluid in Finnish patients with Alzheimer's disease","volume":"95","author":"Lehtimaki","year":"1995","journal-title":"Hum. Genet."},{"key":"10.1006\/nbdi.1999.0273_RF32","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S0091-3057(96)00412-1","article-title":"Reduced levels of antioxidants in brains of APOE-deficient mice following closed head injury","volume":"56","author":"Lomnitski","year":"1997","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1006\/nbdi.1999.0273_RF33","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1212\/WNL.45.8.1594","article-title":"Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease","volume":"45","author":"Lovell","year":"1995","journal-title":"Neurology"},{"key":"10.1006\/nbdi.1999.0273_RF34","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1002\/ana.410360429","article-title":"Apolipoprotein E4 allele doses in late-onset Alzheimer's disease","volume":"36","author":"Lucotte","year":"1994","journal-title":"Ann. Neurol."},{"key":"10.1006\/nbdi.1999.0273_RF35","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1046\/j.1471-4159.1997.68052061.x","article-title":"An assessment of oxidative damage to proteins, lipids and DNA in brain from patients with Alzheimer's disease","volume":"68","author":"Lyras","year":"1997","journal-title":"J. Neurochem."},{"key":"10.1006\/nbdi.1999.0273_RF36","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/0361-9230(95)02034-X","article-title":"\u03b2-Amyloid-induced toxicity in rat hippocampal cells: In vitro evidence for the involvement of free radicals","volume":"38","author":"Manelli","year":"1995","journal-title":"Brain Res. Bull."},{"key":"10.1006\/nbdi.1999.0273_RF37","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0197-4580(98)00009-8","article-title":"4-Hydroxynonenal, a product of lipid peroxidation, in increased in the brain in Alzheimer's disease","volume":"19","author":"Markesbery","year":"1998","journal-title":"Neurobiol. Aging"},{"key":"10.1006\/nbdi.1999.0273_RF38","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1006\/exnr.1995.1088","article-title":"Neurodegeneration in the central nervous system of APOE-deficient mice","volume":"136","author":"Masliah","year":"1995","journal-title":"Exp. Neurol."},{"key":"10.1006\/nbdi.1999.0273_RF39","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0006-8993(95)01576-0","article-title":"Increased 3-nitrotyrosine in brains of ApoE-deficient mice","volume":"718","author":"Matthews","year":"1996","journal-title":"Brain Res."},{"key":"10.1006\/nbdi.1999.0273_RF40","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0891-5849(96)00573-4","article-title":"Increased susceptibility of Alzheimer's disease temporal cortex to oxygen free radical-mediated processes","volume":"23","author":"McIntosh","year":"1997","journal-title":"Free Radical Biol. Med."},{"key":"10.1006\/nbdi.1999.0273_RF41","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/ng0996-55","article-title":"Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity insults and \u03b2-amyloid peptides","volume":"14","author":"Miyata","year":"1996","journal-title":"Nat. Genet."},{"key":"10.1006\/nbdi.1999.0273_RF42","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1212\/WNL.41.4.479","article-title":"The consortium to establish a registry for Alzheimer's disease (CERAD). II. Standardization of the neuropathological assessment of Alzheimer's disease","volume":"41","author":"Mirra","year":"1991","journal-title":"Neurology"},{"key":"10.1006\/nbdi.1999.0273_RF43","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/00005072-199602000-00009","article-title":"Crosslinking of apolipoprotein E by products of lipid peroxidation","volume":"55","author":"Montine","year":"1996","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1006\/nbdi.1999.0273_RF44","first-page":"437","article-title":"Immunohistochemical detection of 4-hydroxy-2-nonenal adducts in Alzheimer's disease is associated with inheritance of APOE4","volume":"150","author":"Montine","year":"1997","journal-title":"Am. J. Pathol."},{"key":"10.1006\/nbdi.1999.0273_RF45","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1097\/00005072-199708000-00004","article-title":"4-Hydroxy-2-nonenal pyrrole adducts in human neurodegenerative disease","volume":"56","author":"Montine","year":"1997","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1006\/nbdi.1999.0273_RF46","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/00005072-199805000-00005","article-title":"Distribution of reducible 4-hydroxynonenal adduct immunoreactivity in Alzheimer disease is associated with APOE genotype","volume":"57","author":"Montine","year":"1998","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1006\/nbdi.1999.0273_RF47","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/0306-4522(95)00331-C","article-title":"Influence of the apolipoprotein E genotype on amyloid deposition and neurofibrillary tangles formation in Alzheimer's disease","volume":"69","author":"Nagy","year":"1995","journal-title":"Neuroscience"},{"key":"10.1006\/nbdi.1999.0273_RF48","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0003-2697(79)90738-3","article-title":"Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction","volume":"95","author":"Okhawa","year":"1979","journal-title":"Anal. Biochem."},{"key":"10.1006\/nbdi.1999.0273_RF49","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1212\/WNL.47.1.190","article-title":"The apolipoprotein E epsilon 4 allele is associated with increased neuritic plaques and cerebral amyloid angiopathy in Alzheimer's disease and Lewy body variant","volume":"47","author":"Olichney","year":"1996","journal-title":"Neurology"},{"key":"10.1006\/nbdi.1999.0273_RF50","first-page":"158","article-title":"Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase","volume":"70","author":"Paglia","year":"1967","journal-title":"J. Lab. Clin. Med."},{"key":"10.1006\/nbdi.1999.0273_RF51","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1161\/01.ATV.14.4.605","article-title":"APOE-deficient mice are a model of lipoprotein oxidation in atherogenesis","volume":"14","author":"Palinski","year":"1994","journal-title":"Arterioscler. Thromb."},{"key":"10.1006\/nbdi.1999.0273_RF52","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/0006-8993(94)91670-5","article-title":"Selective increase in lipid peroxidation in the inferior temporal cortex in Alzheimer's disease","volume":"645","author":"Palmer","year":"1994","journal-title":"Brain Res"},{"key":"10.1006\/nbdi.1999.0273_RF53","first-page":"738","article-title":"Apolipoprotein E genotype and Alzheimer's diseas","volume":"342","author":"Payami","year":"1993","journal-title":"Lancet"},{"key":"10.1006\/nbdi.1999.0273_RF54","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/ana.410210403","article-title":"Amino acids, glutathione and glutathione transferase activity in the brains of patients with Alzheimer's disease","volume":"21","author":"Perry","year":"1987","journal-title":"Ann. Neurol."},{"key":"10.1006\/nbdi.1999.0273_RF55","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/0005-2760(87)90295-5","article-title":"Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein E-containing lipoproteins","volume":"917","author":"Pitas","year":"1987","journal-title":"Biochem. Biophys. Acta"},{"key":"10.1006\/nbdi.1999.0273_RF56","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/0140-6736(93)91705-Q","article-title":"Apolipoprotein E polymorphism and Alzheimer's disease","volume":"42","author":"Poirier","year":"1993","journal-title":"Lancet"},{"key":"10.1006\/nbdi.1999.0273_RF57","doi-asserted-by":"crossref","first-page":"12260","DOI":"10.1073\/pnas.92.26.12260","article-title":"Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer's disease","volume":"92","author":"Poirier","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/nbdi.1999.0273_RF58","doi-asserted-by":"crossref","DOI":"10.1016\/S0891-5849(99)00102-1","article-title":"Oxidative damage and protection by antioxidants in the frontal cortex of Alzheimer's disease is related to the apolipoprotein E genotype","volume":"27","author":"Ramassamy","year":"1999","journal-title":"Free Rad. Biol. Med."},{"key":"10.1006\/nbdi.1999.0273_RF59","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/0006-8993(89)91178-5","article-title":"Glutathione is present in high concentrations in cultured astrocytes but not in neurons","volume":"493","author":"Raps","year":"1989","journal-title":"Brain Res."},{"key":"10.1006\/nbdi.1999.0273_RF60","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0140-6736(97)80089-X","article-title":"APOE genotyping and response to drug treatment in Alzheimer's disease","volume":"349","author":"Richard","year":"1997","journal-title":"Lancet"},{"key":"10.1006\/nbdi.1999.0273_RF61","doi-asserted-by":"crossref","unstructured":"Saunders, A. M., Schmader, K., Breitner, J. C., Benson, M. D., Brown, W. T., Goldfarb, L., Goldgaber, D., et al.1993Apolipoprotein E epsilon 4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases. Lancet342, 710\u2013711.","DOI":"10.1016\/0140-6736(93)91709-U"},{"key":"10.1006\/nbdi.1999.0273_RF62","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1046\/j.1471-4159.1997.68052092.x","article-title":"4-HNE-derived advanced lipid peroxidation end products are increased in Alzheimer's disease","volume":"68","author":"Sayre","year":"1997","journal-title":"J. Neurochem."},{"key":"10.1006\/nbdi.1999.0273_RF63","doi-asserted-by":"crossref","first-page":"9649","DOI":"10.1073\/pnas.90.20.9649","article-title":"Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer's disease","volume":"90","author":"Schmechel","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/nbdi.1999.0273_RF64","doi-asserted-by":"crossref","first-page":"5710","DOI":"10.1073\/pnas.91.12.5710","article-title":"Advanced Maillard reaction end products are associated with Alzheimer's disease pathology","volume":"91","author":"Smith","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/nbdi.1999.0273_RF65","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/382120b0","article-title":"Oxidative damage in Alzheimer's disease","volume":"382","author":"Smith","year":"1996","journal-title":"Nature"},{"key":"10.1006\/nbdi.1999.0273_RF66","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1111\/j.1471-4159.1992.tb10994.x","article-title":"Lipid composition in different regions of the brains in Alzheimer's disease\/senile dementia of Alzheimer's type","volume":"59","author":"Soderberg","year":"1992","journal-title":"J. Neurochem."},{"key":"10.1006\/nbdi.1999.0273_RF67","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0304-3940(97)00558-2","article-title":"Cerebrospinal fluid apoE and apoA-1 concentrations in early- and late-onset Alzheimer's disease","volume":"231","author":"Song","year":"1997","journal-title":"Neurosci. Lett."},{"key":"10.1006\/nbdi.1999.0273_RF68","doi-asserted-by":"crossref","first-page":"114","DOI":"10.2307\/3577149","article-title":"Stable H2O2-resistant variants of Chinese hamster fibroblasts demonstrate increases in catalase activity","volume":"114","author":"Spitz","year":"1988","journal-title":"Radical Res."},{"key":"10.1006\/nbdi.1999.0273_RF69","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/0891-5849(91)90159-Z","article-title":"Glutathione dependent metabolism and detoxification of 4-hydroxy-2-nonenal","volume":"11","author":"Spitz","year":"1991","journal-title":"Free Radical Biol. Med"},{"key":"10.1006\/nbdi.1999.0273_RF70","doi-asserted-by":"crossref","unstructured":"Stern, Y., Brandt, J., Albert, M., Jacobs, D. M., Liu, X., Bell, K., Marder, K., Sano, M., et al.1997The absence of an apolipoprotein \u03f54 allele is associated with a more aggressive form of Alzheimer's disease. Ann. Neurol.41, 615\u2013620.","DOI":"10.1002\/ana.410410510"},{"key":"10.1006\/nbdi.1999.0273_RF71","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/j.1471-4159.1990.tb08858.x","article-title":"Autopsy samples of Alzheimer's cortex show increased peroxidation in vitro","volume":"55","author":"Subbarao","year":"1990","journal-title":"J. Neurochem"},{"key":"10.1006\/nbdi.1999.0273_RF72","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1046\/j.1471-4159.1994.62031039.x","article-title":"Membrane lipids, selectively diminished in Alzheimer brains, suggest synapse loss as a primary event in early-onset form (type I) and demyelination in late-onset form (type II)","volume":"62","author":"Svennerholm","year":"1994","journal-title":"J. Neurochem."},{"key":"10.1006\/nbdi.1999.0273_RF73","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1093\/clinchem\/34.2.377","article-title":"Concurrent liquid chromatographic assay of retinol, alpha-tocopherol, beta-carotene, lycopene and beta cryptoxanthin in plasma with tocopherol acetate as internal standard","volume":"34","author":"Thurnam","year":"1988","journal-title":"Clin. Chem"},{"key":"10.1006\/nbdi.1999.0273_RF74","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1212\/WNL.38.3.359","article-title":"The NINCDS\u2013ADRDA work group criteria for the clinical diagnosis of probable Alzheimer's disease","volume":"38","author":"Tierney","year":"1988","journal-title":"Neurology"},{"key":"10.1006\/nbdi.1999.0273_RF75","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/0014-5793(94)00922-8","article-title":"Identification of metabolic pathways of the lipid peroxidation product 4-hydroxynonenal by mitochondria isolated from rat kidney cortex","volume":"352","author":"Ullrich","year":"1994","journal-title":"FEBS Lett."},{"key":"10.1006\/nbdi.1999.0273_RF76","first-page":"339","article-title":"Genetics of the apolipoprotein E system in man","volume":"32","author":"Uterman","year":"1980","journal-title":"Am. J. Hum. Genet."},{"key":"10.1006\/nbdi.1999.0273_RF77","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/0006-2952(96)00309-7","article-title":"Oxidation of vitamin E, vitamin C and thiols in rat brain synaptosomes by peroxynitrite","volume":"52","author":"Vatassery","year":"1996","journal-title":"Biochem. Pharmacol."},{"key":"10.1006\/nbdi.1999.0273_RF78","doi-asserted-by":"crossref","first-page":"4766","DOI":"10.1073\/pnas.91.11.4766","article-title":"Advanced glycation end products contribute to amyloidosis in Alzheimer's disease","volume":"91","author":"Vitek","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/nbdi.1999.0273_RF79","doi-asserted-by":"crossref","first-page":"7787","DOI":"10.1073\/pnas.91.16.7787","article-title":"Glycated tau protein in Alzheimer's disease: A mechanism for induction of oxidant stress","volume":"91","author":"Yan","year":"1994","journal-title":"Proc. Natl. Acad. Sci USA"},{"key":"10.1006\/nbdi.1999.0273_RF80","doi-asserted-by":"crossref","DOI":"10.1016\/S0022-2275(20)38094-9","article-title":"Proposed nomenclature of apolipoprotein E isoproteins, APOE genotype, and phenotypes","author":"Zannis","year":"1982","journal-title":"J. Lipid Res."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996199902735?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996199902735?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,5,3]],"date-time":"2021-05-03T06:47:42Z","timestamp":1620024462000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996199902735"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,2]]},"references-count":80,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2000,2]]}},"alternative-id":["S0969996199902735"],"URL":"https:\/\/doi.org\/10.1006\/nbdi.1999.0273","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2000,2]]}}}